141 related articles for article (PubMed ID: 37781206)
1. Characteristics of second primary breast cancer after ovarian cancer: a Korea central cancer registry retrospective study.
Lee EG; Lim J; Ha HI; Lim MC; Chang YJ; Won YJ; Jung SY
Front Oncol; 2023; 13():1208320. PubMed ID: 37781206
[TBL] [Abstract][Full Text] [Related]
2. Risk, molecular subtype and prognosis of second primary breast cancer: an analysis based on first primary cancers.
Li C; Du C; Wang Y; Liu M; Zhao F; Li J; Wang W; Wei X; Qu J; Zhou Z; Zhang Y; Zhang S
Am J Cancer Res; 2023; 13(7):3203-3220. PubMed ID: 37559977
[TBL] [Abstract][Full Text] [Related]
3. Risk of second primary breast cancer among cancer survivors: Implications for prevention and screening practice.
Cheng Y; Huang Z; Liao Q; Yu X; Jiang H; He Y; Yao S; Nie S; Liu L
PLoS One; 2020; 15(6):e0232800. PubMed ID: 32497148
[TBL] [Abstract][Full Text] [Related]
4. Comparing the Characteristics and Outcomes of Male and Female Breast Cancer Patients in Korea: Korea Central Cancer Registry.
Lee EG; Jung SY; Lim MC; Lim J; Kang HS; Lee S; Han JH; Jo H; Won YJ; Lee ES
Cancer Res Treat; 2020 Jul; 52(3):739-746. PubMed ID: 32054149
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and survival of second primary breast carcinoma with extramammary malignancies.
Jing Y; Wang X; Sun B
Front Oncol; 2023; 13():1160370. PubMed ID: 37007094
[TBL] [Abstract][Full Text] [Related]
6. Second Primary Breast Cancer in Young Breast Cancer Survivors.
Brantley KD; Rosenberg SM; Collins LC; Ruddy KJ; Tamimi RM; Schapira L; Borges VF; Warner E; Come SE; Zheng Y; Kirkner GJ; Snow C; Winer EP; Partridge AH
JAMA Oncol; 2024 Apr; ():. PubMed ID: 38602683
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Factors Affecting Survival of Patients With Single Primary Breast Cancer vs Patients With Multiple Primary Cancers in Lifetime, One of Which is Breast Cancer.
Sanli AN; Tekcan Sanli DE; Altundag MK; Aydogan F
Am Surg; 2024 Apr; ():31348241248695. PubMed ID: 38676386
[TBL] [Abstract][Full Text] [Related]
8. Second Primary Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancers after Breast Cancer Diagnosis: Korea Central Cancer Registry.
Ha HI; Lee EG; Lim J; Jung SY; Chang YJ; Won YJ; Lim MC
Cancer Res Treat; 2021 Apr; 53(2):541-548. PubMed ID: 33211942
[TBL] [Abstract][Full Text] [Related]
9. Incidence and treatment outcomes of ovarian carcinosarcoma from the national cancer registry of Korea.
Ha HI; Kim JH; Lim J; Song YJ; Won YJ; Lim MC
J Gynecol Oncol; 2024 Jan; 35(1):e31. PubMed ID: 38072401
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
11. Tumor marker phenotype concordance in second primary breast cancer, California, 1999-2004.
Brown M; Bauer K; Pare M
Breast Cancer Res Treat; 2010 Feb; 120(1):217-27. PubMed ID: 19629680
[TBL] [Abstract][Full Text] [Related]
12. Decrease in the prevalence of IL-4-producing CD4+ T cells in patients with advanced stage of primary biliary cirrhosis.
Sekiya H; Komatsu T; Isono E; Furukawa M; Matsushima S; Yamaguchi N; Yamauchi K; Hayashi N
Am J Gastroenterol; 1999 Dec; 94(12):3589-94. PubMed ID: 10606324
[TBL] [Abstract][Full Text] [Related]
13. Trends in the Incidence and Survival Rates of Primary Ovarian Clear Cell Carcinoma Compared to Ovarian Serous Carcinoma in Korea.
Kim SI; Ha HI; Eoh KJ; Lim J; Won YJ; Lim MC
Front Oncol; 2022; 12():874037. PubMed ID: 35463304
[TBL] [Abstract][Full Text] [Related]
14. Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer.
Bui KT; Willson ML; Goel S; Beith J; Goodwin A
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013538. PubMed ID: 32141074
[TBL] [Abstract][Full Text] [Related]
15. The changes of subtype markers between first and second primary breast cancers.
Li C; Lyu Z; Wang Z; Hao C; Huang Y; Song F
Cancer Med; 2023 Jun; 12(12):13649-13660. PubMed ID: 37096879
[TBL] [Abstract][Full Text] [Related]
16. Racial differences in the risk of second primary bladder cancer following radiation therapy among localized prostate cancer patients.
Zhang L; Hsieh MC; Allison C; Devane M; Hicks C; Yu Q; Shi L; Wu J; Wu XC
Cancer Epidemiol; 2021 Aug; 73():101967. PubMed ID: 34146916
[TBL] [Abstract][Full Text] [Related]
17. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
18. Incidence and outcomes of malignant ovarian germ cell tumors in Korea, 1999-2017.
Park M; Lim J; Lee JA; Park HJ; Park BK; Lim MC; Park SY; Won YJ
Gynecol Oncol; 2021 Oct; 163(1):79-84. PubMed ID: 34392955
[TBL] [Abstract][Full Text] [Related]
19. Declining second primary ovarian cancer after first primary breast cancer.
Schonfeld SJ; Berrington de Gonzalez A; Visvanathan K; Pfeiffer RM; Anderson WF
J Clin Oncol; 2013 Feb; 31(6):738-43. PubMed ID: 23284037
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]